Company / Accounts Receivable
CV Sciences, Inc. Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$402.0K
FY2025
5-year range
$402.0K / $2.0M
FY2021-FY2025
Trend
-23.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable has fluctuated over the past 10 years, ranging from $360,475 in FY2016 to $3M in FY2018.
Based on SEC 10-K filings.
$402,000 in FY2025 with a 5-year CAGR of -18.6%.
Declined from $431,000 to $402,000 over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -19.3%
- 5-Year CAGR
- -18.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -18.6%, indicating a declining trend.
- In FY2025, accounts receivable decreased 23.0% year-over-year.
- Peak accounts receivable was recorded in FY2018.
- Lowest accounts receivable in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -8.81 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $402.0K | -23.0% |
| FY2024 | $522.0K | +21.1% |
| FY2023 | $431.0K | -43.7% |
| FY2022 | $766.0K | -62.5% |
| FY2021 | $2.0M | +81.3% |
| FY2020 | $1.1M | -48.3% |
| FY2019 | $2.2M | -34.8% |
| FY2018 | $3.3M | +121.6% |
| FY2017 | $1.5M | +318.1% |
| FY2016 | $360.5K | -58.6% |